Propofol vs. Ketami
- Conditions
- major depression, bipolar disorderTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
- Registration Number
- EUCTR2012-001341-41-AT
- Lead Sponsor
- niversitätsklinik für Psychiatrie und Psychotherapie I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
patient with depression, older than 18 years
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 40
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Encephalitis disseminata
fresh myocardial infarct or stroke
pacemaker
cerebral lesion expansion
psychiatric comorbidity of F1 in ICD-10
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Timepoint(s) of evaluation of this end point: 4 weeks;Main Objective: better therapeutic effect of ketamin in the treatment of ECT ;Secondary Objective: n.a.;Primary end point(s): good therapeutic effect of ketamin in the treatment of ect
- Secondary Outcome Measures
Name Time Method Secondary end point(s): n.a.;Timepoint(s) of evaluation of this end point: 2 years